Brad Bailey, Senior Vice President and General Manager, and Ron Graybill, Vice President of Market Access of Genmab discuss the preparations that Genmab is undertaking to get ready to enter the US market. The focus of Genmab’s market access is geared to enabling physicians, patients, and caregivers to navigate a complex US healthcare to get the right medicine to the patient at the right time.